Aspartoacylase suppresses prostate cancer progression by blocking LYN activation
Abstract Background Globally, despite prostate cancer (PCa) representing second most prevalent malignancy in male, the precise molecular mechanisms implicated in its pathogenesis remain unclear. Consequently, elucidating the key molecular regulators that govern disease progression could substantiall...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
KeAi Communications Co., Ltd.
2023-06-01
|
| Sarja: | Military Medical Research |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s40779-023-00460-0 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|